the US Food and Drug Administration’s
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
‘Sexual Chocolate’ Faces Recalls After FDA Tests Reveal Undisclosed Viagra
The US Food and Drug Administration regularly announces recalls. But it has recently issued a surprising series of alerts: Several brands of chocolate marketed for “sexual enhancement” contain undisclosed drugs prescribed for erectile dysfunction, according to lab analyses conducted by the agency. The flagged products—some of which are being voluntarily recalled—are sold online under names like Boner Bears Chocolate, DTF Sexual Chocolate, Lovion Chocolate With Ginseng for Men, and Rhino...
Jabra Promo Codes: 30% Off Headphones, Headsets & More
Although the US Food and Drug Administration’s move in 2022 to legalize over-the-counter hearing aids helped to move the needle a little, hearing aids are notoriously expensive devices, and the category is still dominated by pricey gear. Jabra has been at the forefront of the OTC hearing aid market since the beginning, aided by a ruthless devolution to continuously refining its audio processing chips and employing always-available audiologists who can tune the devices remotely. The company...
'Transformative' pancreatic cancer drug doubles survival time
A daily pill doubles the survival time of people with pancreatic cancer, one of the most aggressive and difficult-to-treat forms of the condition, even after they have stopped responding to chemotherapy. What’s more, the convenient pill has fewer side effects than standard chemotherapy. “It’s a transformative treatment,” says Pilar Acedo at University College London, who wasn’t involved in the research.
Is the peptide craze backed by science? The promise behind the hype
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer).
Hearing loss is bad for the whole body – but new treatments are coming
I’m sitting in a soundproof booth at an audiologist’s office, wearing headphones and straining to hear some faint electronic noises. When I think I’ve heard one, I press a button. Was that real or did I imagine it?
Urgent baby product recall over risk of causing 'life-threatening infections'
Urgent baby product recall over risk of causing 'life-threatening infections' The company received reports from customers who claimed they experienced adverse reactions after using the products, with symptoms including skin irritation, eye irritation and infections. Parents are being urged to check their homes after a popular range of baby wipes was recalled over fears they could cause serious and potentially life-threatening infections. Target has voluntarily recalled several Up & Up baby...
When drug discovery fails: scientists share their frustrations with the process
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer).
Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer
Abstract BRAF gain-of-function mutations, particularly BRAF(V600E), affect roughly 10% of all patients with colorectal cancer (CRC), and portend poor prognosis with limited therapeutic interventions. BRAF inhibitors such as encorafenib are ineffective due to MAPK pathway reactivation driven by BRAF dimerization. Combined inhibition of BRAF and EGFR, although approved therapies, results in short survival benefits and frequent treatment resistance and relapse1,2,3.
13 Environmentally Conscious Packing Tips for Your Next Vacation
Your trip’s environmental footprint starts forming before you ever leave the house. If you pack wisely, there’s a lot you can do to reduce the negative impact that traveling can have on the planet. Here’s a short list of ecofriendly guidelines to get you going.
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy. Wainberg, co-director of UCLA Health’s GI Oncology Program, was leading a clinical trial of a new drug called daraxonrasib. All the study participants previously had chemotherapy that was starting to fail.